Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
View Session ViewAttendees 36

Adult ID

Epidemiology & Infection Control
Symposium

58 - SARS-CoV-2 Variants and Breakthrough Infections: Implications for Infection Prevention and Control

Thursday, September 30, 2021
5:15 PM - 6:30 PM EDT

    Moderator(s)

  • Alex Kallen, MD MPH

    Branch Chief
    Centers for Disease Control and Prevention
    Atlanta, GA, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • Vivian Leung, MD

    Expert, Antimicrobial Consumption
    European Centre for Disease Prevention and Control (ECDC)
    Solna, Sweden

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

    • Speaker(s)

  • John Jernigan, MD, MS

    Director, Office of Prevention Research and Evaluation
    Division of Healthcare Quality Promotion
    Centers for Disease Control and Prevention
    Atlanta, GA, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • AM

    Adam MacNeil, PhD, MPH

    Epidemiologist
    Centers for Disease Control and Prevention, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

Participants should be aware of the following financial/non-financial relationships:
Alex Kallen, MD MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Vivian Leung, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
John A. Jernigan, MD, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Adam MacNeil, PhD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit

No CPE credits

Learning Objectives:

At the conclusion of this session, participants will be able to:
  • review the epidemiology of SARS-CoV-2 variants
  • describe how variant surveillance is performed and how significance is determined
  • discuss the implications of SARS-CoV-2 breakthrough infections for infection control

Presentations:

  • Breakthrough sars-cov-2 Infections: Implications for Infection Control

    Speaker: John A. Jernigan, MD, MS – Centers for Disease Control and Prevention

  • Epidemiology of SARS-CoV-2 Variants

    Speaker: Adam MacNeil, PhD, MPH – Centers for Disease Control and Prevention